191 related articles for article (PubMed ID: 8190111)
1. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
van de Water B; van Berkel TJ; Kuiper J
Mol Pharmacol; 1994 May; 45(5):971-7. PubMed ID: 8190111
[TBL] [Abstract][Full Text] [Related]
2. Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance.
Karpoff HM; Jarnagin W; Delman K; Fong Y
Surgery; 2000 Aug; 128(2):213-8. PubMed ID: 10922994
[TBL] [Abstract][Full Text] [Related]
3. Induction of macrophage antitumor activity by acetylated low density lipoprotein containing lipophilic muramyl tripeptide.
Shaw JM; Futch WS; Schook LB
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6112-6. PubMed ID: 3413079
[TBL] [Abstract][Full Text] [Related]
4. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.
Fidler IJ; Fogler WE; Brownbill AF; Schumann G
J Immunol; 1987 Jun; 138(12):4509-14. PubMed ID: 3584979
[TBL] [Abstract][Full Text] [Related]
5. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
Fogler WE; Fidler IJ
Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
[TBL] [Abstract][Full Text] [Related]
6. Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.
Maeda M; Knowles RD; Kleinerman ES
Cancer Commun; 1991; 3(10-11):313-21. PubMed ID: 1722107
[TBL] [Abstract][Full Text] [Related]
7. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
Kleinerman ES
Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
[TBL] [Abstract][Full Text] [Related]
8. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes.
Asano T; McWatters A; An T; Matsushima K; Kleinerman ES
J Pharmacol Exp Ther; 1994 Feb; 268(2):1032-9. PubMed ID: 8113959
[TBL] [Abstract][Full Text] [Related]
9. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
10. Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma.
Nardin A; Lefebvre ML; Labroquère K; Faure O; Abastado JP
Curr Cancer Drug Targets; 2006 Mar; 6(2):123-33. PubMed ID: 16529542
[TBL] [Abstract][Full Text] [Related]
11. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
[TBL] [Abstract][Full Text] [Related]
12. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
13. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides.
Dieter P; Hempel U; Kamionka S; Kolada A; Malessa B; Fitzke E; Tran-Thi TA
Mediators Inflamm; 1999; 8(6):295-303. PubMed ID: 10815618
[TBL] [Abstract][Full Text] [Related]
15. Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice.
Fogler WE; Wade R; Brundish DE; Fidler IJ
J Immunol; 1985 Aug; 135(2):1372-7. PubMed ID: 4008926
[TBL] [Abstract][Full Text] [Related]
16. The lipophilic muramyltripeptide MTP-PE, a biological response modifier, is an activator of protein kinase C.
Meyer T; Fabbro D; Eppenberger U; Matter A
Biochem Biophys Res Commun; 1986 Nov; 140(3):1043-50. PubMed ID: 3465326
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
18. In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide.
Goldbach P; Dumont S; Kessler R; Poindron P; Stamm A
Am J Physiol; 1996 Mar; 270(3 Pt 1):L429-34. PubMed ID: 8638735
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells.
Kurzman ID; Shi F; Vail DM; MacEwen EG
Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295
[TBL] [Abstract][Full Text] [Related]
20. MTP-PE: induction of tumoricidal leukocytes in the lungs of rats.
Brownbill AF; Schumann G
Cancer Detect Prev; 1988; 12(1-6):161-8. PubMed ID: 3180123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]